Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by LithLoveron Dec 21, 2021 10:59am
99 Views
Post# 34250450

RE:RE:RE:RE:RE:Down down down

RE:RE:RE:RE:RE:Down down downWow thats a big pile of negativity for someone who sold early and now holds no shares.  Try to lighten up its almost the holidays.  



Liked2Think wrote: Makes you kinda wonder just how well its going then eh?

Can you imagine working on a product for years upon years.  "Releasing" it april 2021 but then not being able to brag at all in how well its doing for the next 9 months.

Same thing goes for their "return to Q1 covid testing numbers"

Remember when they actually gave a preview on covid testing revenue that one quarter.  Nothing like that has ever happened again.

Imagine if covid had not happened.  Forget the covid revenue as Stage is a cancer company BS but if aristotle isnt blowing up right now when its hard to go to the doctor and get normal cancer screening done how would Stage ever would had been able to sell this test without covid shutting everyting down.

Maybe thats why colonsentry did nothing for revenue?  And maybe thats why the pumpers are so desparate for omnicrom or delta or whatever the next variant is going to do this and that.

without covid there is no stagezero from either a covid testing or cancer testing view




<< Previous
Bullboard Posts
Next >>